From: Takotsubo syndrome associated with cardioversion: a systematic review
Study | Age | Sex | Co morbidities | Cardioverted rhythm | Joules applied HO | Time to develop TS (hours) | Complications | Cardiovascular, inotropic or mechanical support needed |
---|---|---|---|---|---|---|---|---|
Alishetti2018 [12] | 77 | F | NM | Atrial flutter | 150 | < 1 | Cardiogenic shock, heart failure | Dopamine switched to epinephrine drip |
Buchter [13] | 66 | F | Hypertension | Atrial fibrillation | NM | NM | Thromboembolism, Cardiogenic shock | NM |
Eggleton 14] | 76 | F | Smoker, Hyperlipidemia, Hypertension | Atrial fibrillation | NM | 10 | Pulmonary edema, cardiogenic shock | Dopamine |
McCutcheon [15] | 87 | F | Hypertension, Hyperlipidemia, Mitral Valve Prolapse, Chronic Kidney Disease, | Atrial fibrillation | 100 | 28 | Pulmonary edema, Heart failure | None |
Pir [16] | 81 | F | Hypertension | Atrial fibrillation | 150 | 48 | Pulmonary edema, Heart failure | None |
Shah [17] | 87 | F | Hypertension, Hyperlipidemia | Atrial fibrillation | 200 | 24 | Heart failure, Died on post-hospital follow-up | None |
Siegfried [18] | 67 | F | Hypertension | Atrial fibrillation | 200 | NM | Cardiogenic shock | Epinephrine, vasopressin and dobutamine |
Smyrlis [19] | 61 | F | Hypertension | Atrial fibrillation | 120 | 4 | Pulmonary edema, Heart failure | None |
Vizzardi [20] | 81 | F | Hypertension, Hyperlipidemia | Atrial fibrillation | NM | 24 | Pulmonary edema, Cardiogenic shock | Dobutamine, dopamine |
Zaghlol [21] | 73 | M | Hypertension, Hyperlipidemia | Atrial flutter | 200 | 3 | Heart failure, pulmonary edema | None |
Valentino [22] | 84 | F | Hypertension | Atrial flutter | NM | immediately | NM | NM |